Boron Molecular

Established in 2001, Boron Molecular is a leading specialist chemical manufacturer. The company was formed around a suite of process patents on organic molecules called boronic acids, which were originally developed by the CSIRO. The team consists of chemists and chemical engineers with a wide range of expertise across a number of chemical and related industries. Boron Molecular’s core business is the synthesis and production of multi-kilo quantities of early and late stage building blocks for export to the global pharmaceutical industries. In 2004, Boron Molecular established a fully integrated operation in North Carolina, USA to compliment its research, development and manufacturing facilities in Melbourne, Australia. As a company Boron Molecular has been able to develop strong quality, documentation, and communication systems to ensure that clients are constantly aware of project status, which has led to a reputation for excellence in technology transfer projects with companies situated in the US, UK, Japan and Australia. Over the last five years Boron Molecular has invested heavily in research and development through collaboration with a range of university partners. Most notably, it has applied its excellence in technology transfer to a range of projects with the CSIRO. As a result, Boron Molecular and CSIRO signed a Master License Agreement in 2015, which established a dynamic legal framework for the commercialization of a host CSIRO technologies. This investment in technology has ultimately led to increase in jobs and the manufacture of new diversified product offering base and expansion of Boron Molecular’s export markets.